{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:30:51Z","timestamp":1787671851497,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00210-026-05530-3","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:02:52Z","timestamp":1780545772000},"page":"17971-17982","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and treatment of low-dose methotrexate-related adverse reactions in rheumatoid arthritis: a retrospective study"],"prefix":"10.1007","volume":"399","author":[{"given":"Renzhu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"5530_CR1","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2147\/IMCRJ.S547951","volume":"18","author":"AH Adan","year":"2025","unstructured":"Adan AH, Hirsi SA, Jayte M (2025) Diagnostic and management challenges of rheumatoid arthritis-associated interstitial lung disease in a Ugandan patient: a case report. Int Med Case Rep J 18:1569\u20131573. https:\/\/doi.org\/10.2147\/IMCRJ.S547951","journal-title":"Int Med Case Rep J"},{"issue":"9","key":"5530_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/ard.54.9.708","volume":"54","author":"GS Alarcon","year":"1995","unstructured":"Alarcon GS, Tracy IC, Strand GM, Singh K, Macaluso M (1995) Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients. Ann Rheum Dis 54(9):708\u2013712. https:\/\/doi.org\/10.1136\/ard.54.9.708","journal-title":"Ann Rheum Dis"},{"key":"5530_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14207213","author":"Y Atayan","year":"2025","unstructured":"Atayan Y, Yolbas S, Bodakci E (2025) Liver enzyme elevations in rheumatoid arthritis: clinical relevance and influence on treatment strategies. J Clin Med. https:\/\/doi.org\/10.3390\/jcm14207213","journal-title":"J Clin Med"},{"key":"5530_CR4","doi-asserted-by":"publisher","DOI":"10.1590\/1678-7757-2022-0115","volume":"30","author":"Z Bayramoglu","year":"2022","unstructured":"Bayramoglu Z, Mokhtare B, Mendil AS, Coban TA, Mammadov R, Bulut S et al (2022) Effect of taxifolin on methotrexate-induced oxidative and inflammatory oral mucositis in rats: biochemical and histopathological evaluation. J Appl Oral Sci 30:e20220115. https:\/\/doi.org\/10.1590\/1678-7757-2022-0115","journal-title":"J Appl Oral Sci"},{"issue":"3","key":"5530_CR5","first-page":"347","volume":"37","author":"C Croia","year":"2019","unstructured":"Croia C, Bursi R, Sutera D, Petrelli F, Alunno A, Puxeddu I (2019) One year in review 2019: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 37(3):347\u2013357","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"5530_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12016-018-8672-5","volume":"56","author":"EG Favalli","year":"2019","unstructured":"Favalli EG, Biggioggero M, Crotti C, Becciolini A, Raimondo MG, Meroni PL (2019) Sex and management of rheumatoid arthritis. Clin Rev Allergy Immunol 56(3):333\u2013345. https:\/\/doi.org\/10.1007\/s12016-018-8672-5","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"5530_CR7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/rheumatology\/key121","volume":"57","author":"MC Genovese","year":"2018","unstructured":"Genovese MC, van Adelsberg J, Fan C, Graham N, van Hoogstraten H, Parrino J et al (2018) Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes. Rheumatology (Oxford) 57(8):1423\u201331. https:\/\/doi.org\/10.1093\/rheumatology\/key121","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"5530_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/ard.2008.089276","volume":"69","author":"JD Greenberg","year":"2010","unstructured":"Greenberg JD, Reed G, Kremer JM, Tindall E, Kavanaugh A, Zheng C et al (2010) Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Ann Rheum Dis 69(2):380\u20136. https:\/\/doi.org\/10.1136\/ard.2008.089276","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"5530_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/15563650.2025.2532616","volume":"63","author":"C Kennedy","year":"2025","unstructured":"Kennedy C, Thompson JA (2025) Methotrexate-induced epidermal necrosis. Clin Toxicol 63(10):789\u2013790. https:\/\/doi.org\/10.1080\/15563650.2025.2532616","journal-title":"Clin Toxicol"},{"issue":"8","key":"5530_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/rheumatology\/keh685","volume":"44","author":"AY Lim","year":"2005","unstructured":"Lim AY, Gaffney K, Scott DG (2005) Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years. Rheumatology 44(8):1051\u20131055. https:\/\/doi.org\/10.1093\/rheumatology\/keh685","journal-title":"Rheumatology"},{"issue":"7","key":"5530_CR11","first-page":"1276","volume":"25","author":"S Monjanel-Mouterde","year":"1998","unstructured":"Monjanel-Mouterde S, Lafforgue P, Blanc A, Catalin J, Aquaviva PC, Durand A (1998) Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis. J Rheumatol 25(7):1276\u20131281","journal-title":"J Rheumatol"},{"issue":"1","key":"5530_CR12","first-page":"36","volume":"25","author":"Z Ortiz","year":"1998","unstructured":"Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P (1998) The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. J Rheumatol 25(1):36\u201343","journal-title":"J Rheumatol"},{"key":"5530_CR13","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2147\/CCID.S528734","volume":"18","author":"Y Ratanapokasatit","year":"2025","unstructured":"Ratanapokasatit Y, Jurairattanaporn N (2025) Methotrexate-induced leukocytoclastic vasculitis: a case report and literature review. Clin Cosmet Inv Derm 18:2005\u20132012. https:\/\/doi.org\/10.2147\/CCID.S528734","journal-title":"Clin Cosmet Inv Derm"},{"issue":"7","key":"5530_CR14","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/ard.2008.093690","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, van der Heijde D (2009) Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 68(7):1100\u20131104. https:\/\/doi.org\/10.1136\/ard.2008.093690","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5530_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102528","volume":"19","author":"L Serhal","year":"2020","unstructured":"Serhal L, Lwin MN, Holroyd C, Edwards CJ (2020) Rheumatoid arthritis in the elderly: characteristics and treatment considerations. Autoimmun Rev 19(6):102528. https:\/\/doi.org\/10.1016\/j.autrev.2020.102528","journal-title":"Autoimmun Rev"},{"issue":"1","key":"5530_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40199-020-00379-0","volume":"29","author":"M Shafie","year":"2021","unstructured":"Shafie M, Abbaszadeh M, Sharifi F (2021) Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction. Daru 29(1):205\u2013209. https:\/\/doi.org\/10.1007\/s40199-020-00379-0","journal-title":"Daru"},{"issue":"11","key":"5530_CR17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.96328","volume":"17","author":"J Shin","year":"2025","unstructured":"Shin J, Parker M, Ditchek JJ, Kesselman MM (2025) The impact of methotrexate on patients with rheumatoid arthritis-associated interstitial lung disease: a systematic literature review. Cureus J Med Sci 17(11):e96328. https:\/\/doi.org\/10.7759\/cureus.96328","journal-title":"Cureus J Med Sci"},{"issue":"10055","key":"5530_CR18","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"issue":"2","key":"5530_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/14397595.2021.1912922","volume":"32","author":"T Sugihara","year":"2022","unstructured":"Sugihara T, Kawahito Y, Morinobu A, Kaneko Y, Seto Y, Kojima T et al (2022) Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. Mod Rheumatol 32(2):313\u2013322. https:\/\/doi.org\/10.1080\/14397595.2021.1912922","journal-title":"Mod Rheumatol"},{"issue":"9","key":"5530_CR20","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/ibd\/izaf035","volume":"31","author":"E Vermeer","year":"2025","unstructured":"Vermeer E, Struys EA, Lin M, van Limbergen JE, de Boer N, Bulatovic-Calasan M et al (2025) Erythrocyte methotrexate-polyglutamate concentrations in pediatric inflammatory bowel disease. Inflamm Bowel Dis 31(9):2503\u201310. https:\/\/doi.org\/10.1093\/ibd\/izaf035","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"5530_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jbspin.2018.09.006","volume":"86","author":"T Vial","year":"2019","unstructured":"Vial T, Patat AM, Boels D, Castellan D, Villa A, Theophile H et al (2019) Adverse consequences of low-dose methotrexate medication errors: data from French poison control and pharmacovigilance centers. Joint Bone Spine 86(3):351\u20135. https:\/\/doi.org\/10.1016\/j.jbspin.2018.09.006","journal-title":"Joint Bone Spine"},{"key":"5530_CR22","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2026.13544","author":"P Wang","year":"2026","unstructured":"Wang P, Liang C, Lin L, Lan J, Zhang Y, Xie W (2026) MTX pathway gene variants, erythrocyte methotrexate polyglutamates, and treatment outcomes in rheumatoid arthritis. Biomol Biomed. https:\/\/doi.org\/10.17305\/bb.2026.13544","journal-title":"Biomol Biomed"},{"issue":"3","key":"5530_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/cei\/uxac010","volume":"207","author":"Y Xie","year":"2022","unstructured":"Xie Y, Jiang X, Wang P, Zheng X, Song J, Bai M et al (2022) SR-A neutralizing antibody: potential drug candidate for ameliorating osteoclastogenesis in rheumatoid arthritis. Clin Exp Immunol 207(3):297\u2013306. https:\/\/doi.org\/10.1093\/cei\/uxac010","journal-title":"Clin Exp Immunol"},{"key":"5530_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1015130","volume":"13","author":"B Zhou","year":"2022","unstructured":"Zhou B, Dong C, Zhao B, Lin K, Tian Y, Zhang R et al (2022) Bacteroides fragilis participates in the therapeutic effect of methotrexate on arthritis through metabolite regulation. Front Microbiol 13:1015130. https:\/\/doi.org\/10.3389\/fmicb.2022.1015130","journal-title":"Front Microbiol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05530-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05530-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05530-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:54:07Z","timestamp":1787669647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05530-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5530"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05530-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed and approved by the Ethics Committee of Xiangtan Central Hospital (Approval No. 2024\u201306-001).This study is a retrospective observational study. With the approval of the ethics committee, the informed consent form was waived.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that no AI was used in the creation of this manuscript.","order":2,"name":"Ethics","label":"Generative AI statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}